Lipids in Health and Disease

Table 2 Risk factor control at baseline and at the 8-month follow-up

From: Lipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectoris

	Baseline			8-month follow-up
	NC progression	NC regression	p value	NC progression	NC regression	p value
	(n = 74)	(n = 45)		(n = 74)	(n = 45)
TC (mg/dL)	208 ± 35	200 ± 37	0.22	159 ± 26	157 ± 32	0.68
% change				−22 ± 12	−21 ± 13	0.46
LDL-C (mg/dL)	133 ± 31	129 ± 32	0.48	85 ± 22	85 ± 29	0.91
% change				−36 ± 14	−34 ± 18	0.48
Triglycerides (mg/dL)	130 ± 71	132 ± 55	0.92	122 ± 67	108 ± 57	0.26
% change				1 ± 46	−14 ± 37	0.07
HDL-C (mg/dL)	47 ± 12	45 ± 10	0.3	51 ± 13	51 ± 13	0.86
% change				10 ± 25	13 ± 23	0.54
Hs-CRP (ng/mL)	4750 (103 to 88900)	3300 (54 to 76800)	0.57	654 (52 to 26200)	582 (78 to 23300)	0.98
% change				−40 ± 113	−45 ± 73	0.79
Small dense LDL (mg/dL)	26 ± 14	26 ± 13	0.96	18 ± 8	20 ± 10	0.45
% change				−15 ± 52	−19 ± 32	0.76
Oxidized LDL (U/mL)	13 ± 9	10 ± 7	0.08	11 ± 8	9 ± 9	0.18
% change				−3 ± 43	11 ± 166	0.52
Lipoprotein(a) (mg/dL)	16 (3 to 47)	12 (1 to 43)	0.02	17 (1 to 118)	10 (1 to 60)	0.006
% change				26 ± 53	12 ± 49	0.16

Data are expressed as mean ± SD or median (range).
NC, necrotic core; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; Hs-CRP, high-sensitivity C-reactive protein; LDL, low density lipoprotein.

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com